Cardiovascular Disease in Diabetes-Reference-Cited by-同舟云学术

Cardiovascular Disease in Diabetes

Published:2008-06-01 Issue:6 Volume:31 Page:1260-1266
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Bloomgarden Zachary T.¹

Affiliation:

1. Zachary T. Bloomgarden, MD, is a practicing endocrinologist in New York, New York, and is affiliated with the Division of Endocrinology, Mount Sinai School of Medicine, New York, New York

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/31/6/1260/599336/zdc00608001260.pdf

Reference62 articles.

1. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234, 1998

2. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Heller GV, Filipchuk N, Engel S, Ratner RE, Iskandrian AE, the Detection of Ischemia in Asymptomatic Diabetics Investigators: Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 27:1954–1961, 2004

3. Libby P, Plutzky J: Diabetic macrovascular disease: the glucose paradox? Circulation 106:2760–2763, 2002

4. American Diabetes Association: Standards of medical care in diabetes—2008 (Position Statement). Diabetes Care 31(Suppl. 1):S12–S54, 2008

5. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS; COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356:1503–1516, 2007

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ldlr-Deficient Mice with an Atherosclerosis-Resistant Background Develop Severe Hyperglycemia and Type 2 Diabetes on a Western-Type Diet;Biomedicines;2022-06-16

2. Development of a Complex Intervention for Effective Management of Type 2 Diabetes in a Developing Country;Journal of Clinical Medicine;2022-02-22

3. Type 2 diabetes: evidence-based medicine approach to glucose-lowering therapy;Meditsinskiy sovet = Medical Council;2021-01-17

4. A NEW INDICATION FOR EMPAGLIFLOZIN: TURNING POINT IN THE TREATMENT OF TYPE 2 DIABETES;Medical Council;2017-12-30

5. Assessment of preclinical pharmacokinetics and acute toxicity of pioglitazone and telmisartan combination;Regulatory Toxicology and Pharmacology;2017-12